Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $347.00 | $19.08 | 1,719.00% | 6,940.00x | 102.44x | 7.69x | 9.31x | 6.70x | $529.27M | 1.38% | $4.13B | 37.48 | $36.30B | 114.16 | ||
| NVO | NOVO NORDISK A S | $43.34 | $147.61 | -70.64% | 11.88x | 1.90x | 3.96x | 6.30x | 0.12x | $9.33B | 4.82% | $30.70B | 6.88 | $210.05B | 8.70 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $331.24 | $36.36 | 811.06% | 1,068.52x | 49.45x | 13.56x | 187.10x | 3.47x | $221.36M | 0.51% | $233.89M | 1.78 | $45.48B | 299.39 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.58 | $17.52 | 143.02% | 86.90x | 26.69x | 5.32x | 6.03x | 1.05x | $101.73M | 3.20% | $535.38M | 7.17 | $3.06B | 57.16 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.36 | $16.26 | -48.59% | 17.42x | 14.77x | 5.54x | 3.53x | 0.22x | -$23.64M | -5.06% | $133.17M | 2.38 | $478.93M | 7.13 | ||
| CORT | CORCEPT THERAPEUTICS INC | $38.36 | $41.23 | -6.95% | 38.36x | 61.99x | 5.36x | 6.39x | 0.39x | $162.57M | 4.09% | $631.90M | 6.10 | $3.92B | 59.36 | ||
| VCEL | VERICEL CORP | $35.38 | $9.46 | 273.80% | 136.08x | 62.42x | 6.90x | 5.56x | 1.61x | $20.38M | 1.14% | $321.86M | 6.38 | $1.79B | 60.96 | ||
| ARGX | ARGENX SE | $820.31 | $366.30 | 123.95% | 32.78x | 27.36x | 26,461.61x | 6.98x | 1.33x | $467.72M | 0.93% | $7.17B | 117.50 | $47.66B | 58.75 | ||
| ABEO | ABEONA THERAPEUTICS INC | $4.90 | $18.91 | -74.09% | 3.08x | -90.91x | 700.00x | 1.55x | 0.18x | -$82.36M | -30.98% | $171.23M | 3.16 | $206.42M | 2.30 | ||
| TECH | BIO-TECHNE CORP | $65.86 | $16.28 | 304.62% | 126.65x | 32.61x | 8.44x | 5.12x | 1.79x | $223.02M | 2.17% | $2.01B | 12.90 | $10.48B | 46.29 | ||
| ADMA | ADMA BIOLOGICS INC | $15.94 | $12.61 | 26.44% | 18.11x | 17.46x | 7.78x | 8.80x | 0.76x | $40.73M | 1.07% | $431.19M | 1.81 | $3.81B | 22.11 | ||
| GMAB | GENMAB A | $30.97 | $126.54 | -75.53% | 13.22x | 1.83x | 5.58x | 3.46x | 0.10x | $1.19B | 6.01% | $5.75B | 8.96 | $18.27B | 9.13 | ||
| KRYS | KRYSTAL BIOTECH INC | $267.64 | $117.75 | 127.30% | 38.79x | 32.14x | 20.76x | 6.82x | 1.24x | $166.02M | 2.14% | $1.14B | 39.30 | $7.38B | 38.17 | ||
| MNKD | MANNKIND CORP | $5.51 | $2.90 | 89.91% | 55.10x | 63.12x | 5.39x | -37.98x | 0.86x | $43.39M | 2.56% | -$44.55M | -0.15 | $1.92B | 26.29 | ||
| VCYT | VERACYTE INC | $34.86 | $12.31 | 183.22% | 89.38x | 30.85x | 5.54x | 2.19x | 1.25x | $98.21M | 3.58% | $1.26B | 15.98 | $2.48B | 43.49 | ||
| RPRX | ROYALTY PHARMA PLC | $44.10 | $46.44 | -5.05% | 25.06x | 8.50x | 8.11x | 2.65x | 0.44x | $2.11B | 11.09% | $9.62B | 22.28 | $33.46B | 32.05 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.26 | $9.75 | 46.31% | 24.59x | 14.95x | 7.07x | 5.14x | 0.80x | $119.87M | 6.37% | $365.77M | 2.78 | $1.89B | 18.21 | ||
| XOMA | XOMA ROYALTY CORP | $24.92 | $15.68 | 58.88% | 30.77x | 79.26x | 6.42x | 3.51x | 0.82x | -$12.41M | -4.10% | $87.94M | 7.25 | $350.02M | 13.09 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $5.13 | $4.28 | 19.89% | 19.00x | 17.05x | 3.28x | 5.79x | 0.68x | $21.15M | 5.17% | $70.68M | 0.89 | $348.17M | 15.34 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $191.69 | $71.54 | 167.93% | 82.98x | 22.66x | 14.94x | 3.97x | 1.19x | $30.76M | 0.82% | $950.17M | 48.53 | $4.08B | 39.65 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $22.56 | $6.09 | 270.49% | 64.46x | -19.63x | 2.81x | 7.12x | 2.00x | $78.64M | 2.76% | $401.17M | 3.17 | $2.85B | 30.51 | ||
| EXEL | EXELIXIS INC | $42.37 | $35.99 | 17.71% | 17.22x | 13.04x | 4.97x | 5.26x | 0.70x | $779.77M | 6.86% | $2.16B | 8.05 | $11.16B | 12.03 | ||
| HALO | HALOZYME THERAPEUTICS INC | $78.42 | $80.39 | -2.45% | 16.04x | 9.41x | 7.40x | 18.30x | 0.54x | $602.40M | 6.55% | $503.92M | 4.30 | $10.31B | 12.20 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.91 | $3.54 | -17.73% | 41.57x | 16.46x | 3.73x | 4.42x | 0.34x | -$11.69M | -5.05% | $52.91M | 0.67 | $228.56M | 25.76 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.91 | $23.26 | 2.80% | 13.36x | 13.17x | 5.07x | 3.19x | 0.66x | $234.54M | 8.00% | $920.25M | 7.51 | $2.25B | 6.95 | ||
| CRMD | CORMEDIX INC | $7.35 | $14.39 | -48.92% | 3.24x | 4.52x | 2.60x | 1.55x | 1.81x | $74.42M | 13.33% | $374.13M | 4.93 | $679.53M | 6.05 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $458.81 | $188.71 | 143.12% | 32.06x | 22.50x | 10.00x | 6.72x | 1.55x | $3.34B | 2.85% | $17.32B | 67.76 | $113.30B | 24.30 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.15 | $50.78 | 12.54% | 21.01x | 12.89x | 3.55x | 1.81x | 0.59x | $832.13M | 7.58% | $6.06B | 31.54 | $10.33B | 13.36 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.41 | $62.69 | -41.92% | 11.27x | 8.42x | 2.54x | 2.51x | 0.30x | $296.89M | 14.17% | $835.12M | 14.51 | $1.62B | 6.00 | ||
| UTHR | UNITED THERAPEUTICS CORP | $478.93 | $252.51 | 89.67% | 16.82x | 16.25x | 6.71x | 3.13x | 1.92x | $1.12B | 5.35% | $6.59B | 150.46 | $19.28B | 10.87 | ||
| INVA | INNOVIVA INC | $21.57 | $19.20 | 12.35% | 11.41x | 9.87x | 3.83x | 1.60x | 0.93x | $196.54M | 13.19% | $1.01B | 14.63 | $1.39B | 6.49 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $766.63 | $441.65 | 73.58% | 17.80x | 16.50x | 5.59x | 2.59x | 1.41x | $4.08B | 5.09% | $31.26B | 298.82 | $80.64B | 13.86 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $23.46 | $12.06 | 94.59% | 14.94x | 30.67x | 3.78x | 4.33x | 2.73x | $197.81M | 5.00% | $917.27M | 5.43 | $3.74B | 13.01 | ||
| MDXG | MIMEDX GROUP INC | $5.03 | $2.66 | 89.38% | 17.96x | 44.83x | 1.89x | 3.12x | 1.72x | $66.82M | 8.97% | $238.95M | 1.61 | $621.08M | 8.97 | ||
| INCY | INCYTE CORP | $102.76 | $75.69 | 35.76% | 17.01x | 12.83x | 4.18x | 4.34x | 0.90x | $1.20B | 5.95% | $4.65B | 23.77 | $17.75B | 10.55 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.